Page last updated: 2024-12-04

nitric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nitric Acid: Nitric acid (HNO3). A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. (From Merck Index, 11th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nitric acid : A nitrogen oxoacid of formula HNO3 in which the nitrogen atom is bonded to a hydroxy group and by equivalent bonds to the remaining two oxygen atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID944
CHEMBL ID1352
CHEBI ID48107
MeSH IDM0027104

Synonyms (154)

Synonym
AKOS015833449
hno3
nitric acid, gallium salt ( )
nitric acid (70% or less)
acide nitrique [french]
nitric acid (red fuming)
un2032
un2031
nitrous fumes
nitric acid (conc 80% or greater)
hsdb 1665
salpeterzuuroplossingen [dutch]
engraver's acid
red fuming nitric acid
nitric acid (hno3) 94.5% by weight or more hno3
nitric acid (greater than 70%)
kyselina dusicne [czech]
nital
rfna
nitryl hydroxide
acido nitrico [italian]
nitric acid, anhydrous
azotowy kwas [polish]
einecs 231-714-2
acido nitrico [spanish]
salpetersaure [german]
acidum nitricum
aqua fortis
12033-49-7
no3 anion
acid, nitric
nitric acid, semiconductor grade vlsi puranal(tm) (honeywell 17512), 69-71%
7697-37-2
nitric acid
C00244
wln: pr n-o3x3
D02313
nitric acid (nf)
nitric acid, acs reagent, >=90.0%
nitric acid, 70%, purified by double-distillation
nitric acid, 70%, purified by redistillation, >=99.999% trace metals basis
nitric acid, acs reagent, 70%
nitric acid, reagent grade, >90%
hydroxidodioxidonitrogen
hono2
acide nitrique
salpetersaeure
[no2(oh)]
trioxonitric acid
azotic acid
CHEBI:48107 ,
hydrogen trioxonitrate(1-)
acide azotique
hydrogen nitrate
nitric acid, puriss. p.a., acs reagent, fuming, >=99.5%
nitric acid, semiconductor grade puranal(tm) (honeywell 17952), >=69%
nitric acid, semiconductor grade puranal(tm) (honeywell 17818), >=65%
nitric acid, semiconductor grade mos puranal(tm) (honeywell 17920), >=69%
3088A493-74F8-4D19-8ABC-E572420B5F29
nitric acid other than red fuming with >70% nitric acid [un2031] [corrosive]
bdbm50152970
CHEMBL1352 ,
N0806
68412-17-9
salpeterzuuroplossingen
nitric acid other than red fuming with not >70% nitric acid
411vrn1tv4 ,
nitric acid, red fuming [un2032] [corrosive]
nitric acid, red fuming
nitricum acidum
ec 231-714-2
nitric acid other than red fuming with not >70% nitric acid [un2031] [corrosive]
unii-411vrn1tv4
acido nitrico
salpetersaure
kyselina dusicne
nitric acid [nf]
azotowy kwas
nitric acid other than red fuming with >70% nitric acid
FT-0689223
medullipin ii
122392-03-4
nitricum acidum [hpus]
nitric acid 65%
nitric acid [hsdb]
nitric acid [mart.]
nitric acid [who-dd]
nitric acid [ii]
nitric acid [mi]
nitric acid [ep monograph]
309963-65-3
153312-87-9
4,4-dioctyl-cyclopenta[2,1-b :3,4-b' ]dithiophene
nitro alcohol
GRYLNZFGIOXLOG-UHFFFAOYSA-N
nitric -acid
nitroalcohol
nitro-alcohol
78989-43-2
mfcd00011349
nitrogen hydroxideoxide (n(oh)2o) (9ci)
DTXSID5029685 ,
nitric acid, acs
nitric acid, 65-70%
nitric acid (67%)
nitric acid, puriss. p.a., 65% (hg <=0.0000005%), >=65% (t)
nitric acid, puriss. p.a., >=65% (t)
nitric acid, reagent grade, fuming, >90%
nitric acid, purum p.a., fuming, packed in coated, shock- and leak-protected glass bottle, >=99% (t)
nitric acid, puriss., 64-66%
nitric acid, jis special grade, >=97.0%, fuming, density: 1.52
nitric acid, red, fuming, hno3 >90 %
nitric acid, jis special grade, 65.0-66.0%, density: 1.40
nitric acid, saj first grade, 60.0-62.0%, density: 1.38
nitric acid, 60.0-62.0%, saj super special grade, density: 1.38
nitric acid, puriss. p.a., acs reagent, reag. iso, >=69%
nitric acid, 70%, meets analytical specification of bp, ph??eur, ph??fran??, usp, fcc, e339
nitric acid, puriss. p.a., reag. iso, reag. ph. eur., for determinations with dithizone, >=65%
nitric acid, jis special grade, 60.0-61.0%, density: 1.38
nitric acid, saj first grade, 90.0-94.0%, fuming, density: 1.50
nitric acid, 0.1 m
nitric acid, saj first grade, >=97.0%, fuming, density: 1.52
nitric acid, 60.0-62.0%, suitable for determination of toxic metals, density: 1.38
nitric acid, saj first grade, 69-70%, density: 1.42
nitric acid, jis special grade, 69.0-70.0%, density: 1.42
nitric acid, jis special grade, 90.0-94.0%, fuming, density: 1.50
nitric acid, 1 m
nitric acid, saj first grade, 65.0-66.0%, density: 1.40
engravers acid
nitric acid, technical grade, 50.0%
nitric acid, 65%
nitric acid, lr, 69-72%
nitric acid, fuming, 99.5%
nitric acid, ar, 69-72%
nitric acid, p.a., 65%
nitric acid, p.a., acs reagent, reag. iso, reag. ph. eur., 68.5-69.5%
nitric acid, extra pure, 69.0-71.0%
nitric acid, p.a., acs reagent, 68.0-70.0%
nitric acid: electronic grade
nitric acid, 90% acs grade
nitric acid, 68-70%, certified acs plus grade trace metal analyzed
nitrosonitric acid
2,3,9,10,16,17-hexachlorinated boron subphthalocyanine
Q27110015
Q83320
nitric acid (15n)
nitric acid (ii)
nitricum acidum 200c
nitric acid (ep monograph)
nitricum acidum 30c
dtxcid509685
nitric acid (mart.)
(no2(oh))
nitric acid blank

Research Excerpts

Overview

Nitric acid (HNO3) vapor is an important nitrogenous air pollutant responsible for increasing saturation of forests with nitrogen. Nitric acid maceration is a rediscovered technique for identifying the nervous anatomy of soft tissues.

ExcerptReferenceRelevance
"Nitric acid (HNO(3)) is a solution of nitrogen dioxide (NO(2)) in water commonly used as an industrial chemical and cleaner. "( Fatal pulmonary edema after acute occupational exposure to nitric acid.
Akbarnia, H; Murphy, CM; Rose, SR, 2010
)
2.05
"Nitric acid (HNO3) vapor is an important nitrogenous air pollutant responsible for increasing saturation of forests with nitrogen and direct injury to plants. "( Passive sampler for measurements of atmospheric nitric acid vapor (HNO3) concentrations.
Arbaugh, MJ; Bytnerowicz, A; Jones, DP; Padgett, PE; Parker, DR, 2001
)
2.01
"Nitric acid was found to be a better modifier than TRITON X-100."( Use of nitric acid in sample pretreatment for determination of trace elements in various biological samples by ETAAS.
Bukovec, P; Cemazar, M; Falnoga, I; Milacic, R; Scancar, J, 2000
)
1.48
"Nitric acid maceration is a rediscovered technique for identifying the nervous anatomy of soft tissues."( The innervation of the triangular fibrocartilage complex: nitric acid maceration rediscovered.
Baker, J; Gupta, R; Jones, NF; Meals, RA; Nelson, SD, 2001
)
1.28

Effects

Nitric acid (NO) has been implicated in the mechanisms of seizure activity and neurodegeneration, which are both very active in the PEHO syndrome. Nitric acid has been used to extract plastic particles from zooplankton.

ExcerptReferenceRelevance
"Nitric acid has been used to extract plastic particles from zooplankton and other biota because it completely digests tissue and exoskeletons, thus reducing interferences."( Quantitative and qualitative impacts of nitric acid digestion on microplastic identification via FTIR and Raman spectroscopy, implications for environmental samples.
Arbuckle-Keil, G; Auguste, C; Chan, J; Fahrenfeld, NL; Ochoa, L; Patil, S; Sipps, K, 2023
)
1.9
"Nitric acid (NO) has recently been implicated in the mechanisms of seizure activity and neurodegeneration, which are both very active in the PEHO syndrome."( The PEHO syndrome.
Riikonen, R, 2001
)
1.03

Treatment

The nitric acid pretreatment generated the most hemicellulose hydrolyzate, while significant reduction of the lignin occurred with sodium hydroxide pretreatment. Nitric acid treatment results in an increase in adsorption capacity of fly ash (2.4 x 10(-5) mol/g) while it decreases the adsorptive capacity for red mud (3.2 x 10 (-6) mol/)

ExcerptReferenceRelevance
"The nitric acid pretreatment was carried out at 30 °C, 200 rpm for 72 h."( A novel approach to produce glucose from the supernatant obtained upon the dilute acid pre-treatment of rice straw and synergistic action of hydrolytic enzymes producing microbes.
Chownk, M; Sangwan, RS; Yadav, SK, 2019
)
0.99
"The nitric acid pretreatment generated the most hemicellulose hydrolyzate, while significant reduction of the lignin occurred with sodium hydroxide pretreatment."( Enhancement of volatile fatty acids production from rice straw via anaerobic digestion with chemical pretreatment.
Chang, HN; Han, JI; Jung, K; Kim, I; Kim, YC; Park, GW; Seo, C, 2015
)
0.9
"Nitric acid treated adsorbent (MWAC 2) was used for column study to determine the constants of bed depth service time (BDST) model for adsorption column design."( Hexavalent chromium [Cr(VI)] removal by acid modified waste activated carbons.
Ghosh, PK, 2009
)
1.07
"The nitric acid-treated anode in MFC-A increased the power density by 58% reaching 2066 mW/m(2)."( Improved performance of membrane free single-chamber air-cathode microbial fuel cells with nitric acid and ethylenediamine surface modified activated carbon fiber felt anodes.
Chen, X; Li, P; Wu, J; Wu, P; Zhang, T; Zhu, N, 2011
)
1.07
"Nitric acid treatment results in an increase in adsorption capacity of fly ash (2.4 x 10(-5) mol/g) while it decreases the adsorption capacity for red mud (3.2 x 10(-6) mol/g)."( Removal of dyes from aqueous solution using fly ash and red mud.
Boyjoo, Y; Choueib, A; Wang, S; Zhu, ZH, 2005
)
1.05
"The treatment with nitric acid 60% is as efficient as conventional treatments, requires less patient compliance of the treatment and produces no pharmacological interactions, providing alternative treatment in the case of hepatotoxicity."( Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis.
Marcos-Tejedor, F; Mayordomo, R; Santos-Carnicero, N, 2021
)
1.22
"AC treated with nitric acid presented a larger amount of oxygen functional groups than materials oxidised with ozone."( Adsorption of volatile sulphur compounds onto modified activated carbons: effect of oxygen functional groups.
Anfruns, A; Gonzalez-Olmos, R; Lemus, J; Martin, MJ; Palomar, J; Vega, E, 2013
)
0.72
"The treatment with nitric acid caused the introduction of a significant number of oxygenated acidic surface groups onto the carbon surface, while the heat treatment increases the basicity of carbon."( Adsorption of benzene and toluene from aqueous solutions onto activated carbon and its acid and heat treated forms: influence of surface chemistry on adsorption.
Ismadji, S; Setiawan, J; Setyadhi, L; Wibowo, D; Wibowo, N, 2007
)
0.66

Toxicity

ExcerptReferenceRelevance
" Because of their unique properties, nanotubes can impose potentially toxic effects, particularly if they have been modified to express functionally reactive chemical groups on their surface."( Influence of acid functionalization on the cardiopulmonary toxicity of carbon nanotubes and carbon black particles in mice.
Devlin, RB; Gilmour, MI; Kodavanti, UP; McGee, JK; Saxena, RK; Tong, H, 2009
)
0.35
" This study was designed to determine the influences of acid functionalization on SWCNT toxicity and to understand the molecular toxic mechanisms."( In vitro toxicity of acid-functionalized single-walled carbon nanotubes: effects on murine macrophages and gene expression profiling.
Dong, PX; Guo, LH; Wan, B, 2012
)
0.38
" However, depending on its origin and on the manufacturing technology, it can result toxic for plants."( Acidification with nitric acid improves chemical characteristics and reduces phytotoxicity of alkaline chars.
Belda, RM; Fornes, F, 2017
)
0.78

Bioavailability

ExcerptReferenceRelevance
" Researchers have studied different partial extraction methods for estimating the bioavailability of mineral pollutants."( Soil and waste analysis for environmental risk assessment in France.
Ciesielski, H; Gomez, A; Sterckeman, T, 1996
)
0.29
" Tungsten appears to be relatively immobile when subjected to sequential extraction but increased bioavailability is indicated when single stage extraction using EDTA is employed."( Bio-availability of tungsten in the vicinity of an abandoned mine in the English Lake District and some potential health implications.
Pyatt, FB; Wilson, B, 2006
)
0.33
" This study underpins the science and importance of metal bioavailability and speciation based site characterisation in mixed contaminated sites."( Finger printing of mixed contaminants from former manufactured gas plant (MGP) site soils: Implications to bioremediation.
Krishnamurti, GS; McFarland, R; Megharaj, M; Naidu, R; Thavamani, P, 2011
)
0.37
" Much lower bioavailability was observed for Al, Ba and Pb."( Elemental composition of dog foods using nitric acid and simulated gastric digestions.
Kelly, DG; Weir, RD; White, SD, 2013
)
0.66
" However, it appears that erythrocytes ability to modulate the bioavailability of nitric oxide (NO) plays a major role in capillary opening and perfusion."( [Erythrocytes and microvascular tone during acute traumatic haemorrhagic shock].
Biais, M; Cassone, O; Delaunay, F; Dubuisson, V; Janvier, G; Morel, N; Morel, O; Siméon, F, 2013
)
0.39
" DEP/MET modified the mucus profile of the epithelium, while DEP/HEX altered mucus extrusion, and these responses might be due to bioavailability of individual elements in DEP fractions."( Organic and inorganic fractions of diesel exhaust particles produce changes in mucin profile of mouse trachea explants.
Corrêa, AT; Junqueira, MS; Macchione, M; Martins, MA; Mauad, T; Saldiva, PH; Seriani, R; Silva, LF; Toledo, AC, 2015
)
0.42
" A risk analysis of the fine fraction of ASR before and after treatment was conducted to assess the bioavailability and eco-toxicity of heavy metals."( Quantitative analysis and reduction of the eco-toxicity risk of heavy metals for the fine fraction of automobile shredder residue (ASR) using H2O2.
Chang, YY; Singh, J; Yang, JK, 2016
)
0.43
"Assessment of heavy metal bioavailability in sediments is complex because of the number of partial extraction methods available for the assessment and the general lack of certified reference materials."( Comparison of partial extraction reagents for assessing potential bioavailability of heavy metals in sediments.
Ayoko, GA; Brady, JP; Goonetilleke, A; Kinaev, I, 2016
)
0.43
" These results were applied to predict the Cd bioavailability after the addition of colza cake to Cd-contaminated soil."( The Combination of DGT Technique and Traditional Chemical Methods for Evaluation of Cadmium Bioavailability in Contaminated Soils with Organic Amendment.
Ding, SM; Miao, LZ; Sun, Q; Wang, C; Wang, PF; Yao, Y, 2016
)
0.43
" In addition, in vitro gastrointestinal digestion was used to assess bioavailability of elements from this food supplement."( Room temperature solvent extraction for simple and fast determination of total concentration of Ca, Cu, Fe, Mg, Mn, and Zn in bee pollen by FAAS along with assessment of the bioaccessible fraction of these elements using in vitro gastrointestinal digestio
Cyganowski, P; Dzimitrowicz, A; Jamroz, P; Lesniewicz, A; Pohl, P; Szymczycha-Madeja, A; Welna, M, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" Dose-response analysis indicated that L-NNA was 87 and 230 times more potent than L-NMA and L-NAA, respectively."( Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Chaudhuri, G; Cuevas, JM; Ignarro, LJ; Vargas, HM, 1991
)
0.28
" This process is not influenced by simultaneous dosage with large amounts of NaNO3."( Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine stimulated by Escherichia coli lipopolysaccharide in the rat.
Leaf, CD; Tannenbaum, SR; Wishnok, JS, 1991
)
0.28
" The peptides produced dose-related increases in perfusion pressure, and dose-response curves to all six peptides were parallel."( Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Garrison, EA; Kadowitz, PJ; Osei, SY; Santiago, JA, 1995
)
0.29
" The dose-response curves elicited by ACh from HCHF diet rabbits were more significantly shifted to the right than those from HCHF diet plus HOE 642-treated rabbits."( [Protective effect of Na(+)-H+ exchanger inhibitor cariporide on the injury of vascular endothelial function induced by hypercholesterolemia].
Liu, LY; Tu, JH; Zhang, XH, 2002
)
0.31
" The dose-response curve for methoxamine was shifted to the right and the maximum contractile response was reduced in mesenteric arterial beds from beef tallow-fed rats, but the modulation of this response induced by L-arginine plus BSA was preserved."( Modulations of shear stress-induced contractile responses and agonist-induced vasodilation in hypercholesterolemic rats.
Kamata, K; Kobayashi, T; Matsumoto, T; Sato, A; Suenaga, H, 2004
)
0.32
"1, H(2)O(2) dosage 83."( Heterogeneous Fenton-like catalytic removal of p-nitrophenol in water using acid-activated fly ash.
Jiang, P; Liu, G; Wang, N; Zhang, A; Zhou, J, 2012
)
0.38
"On the basis of previous test that selenizing Chinese angelica polysaccharides (sCAPs) with stronger immune-enhancing activity in vitro were picked out, the immune-enhancing activity in vivo of three sCAPs, sCAP2, sCAP6 and sCAP8, at high and low dosage were compared taking the unmodified Chinese angelica polysaccharide (CAP) as control by determination of peripheral lymphocyte proliferation, serum antibody titer, IFN-γ and IL-6 contents in chicken vaccinated with Newcastle Disease vaccine."( Selenylation modification can enhance immune-enhancing activity of Chinese angelica polysaccharide.
Chen, J; Gao, Z; Hu, Y; Huang, Y; liu, R; Qin, T; Qiu, S; Wang, D; Wang, M; Wang, Q; Yu, Y; Zhang, J, 2013
)
0.39
" The removal efficiency of uranium and gross radioactivity increased steeply with increasing CaCl2 content, from 10% to 50%, and a HNO3 leaching time from 5 min to 1h, but remained nearly constant or decreased slightly with increasing CaCl2 dosage >50% or acid-leaching time >1h."( Removal of uranium and gross radioactivity from coal bottom ash by CaCl2 roasting followed by HNO3 leaching.
Lei, X; Qi, G; Sun, Y; Wang, Y; Xu, H, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
protic solventA polar solvent that is capable of acting as a hydron (proton) donor.
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
nitrogen oxoacid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Neuroinflammation010

Protein Targets (13)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase Stylophora pistillataKi560.00000.00000.686710.0000AID552130
Carbonic anhydraseStylophora pistillataKi990.00000.00000.50715.7100AID552131
Carbonic anhydrase 1Homo sapiens (human)Ki7,000.00000.00001.372610.0000AID238317; AID238410; AID238513; AID238687; AID552127
Carbonic anhydrase 2Homo sapiens (human)Ki35,000.00000.00000.72369.9200AID238327; AID238440; AID238542; AID238715; AID552128
Carbonic anhydrase 4Homo sapiens (human)Ki58,700.00000.00021.97209.9200AID238441; AID238544
Carbonic anhydrase 6Homo sapiens (human)Ki760.00000.00011.47109.9200AID552129
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki10,666.67200.00001.27259.9000AID238411; AID238515; AID238688
Carbonic anhydraseMethanosarcina thermophilaKi36,500.00000.06000.97148.5000AID238607
Carbonic anhydrase 7Homo sapiens (human)Ki190.00000.00021.37379.9000AID265737
Carbonic anhydrase 9Homo sapiens (human)Ki46,000.00000.00010.78749.9000AID238442; AID238546
Carbonic anhydraseMethanothermobacter thermautotrophicus str. Delta HKi7,800.00005.35005.35005.3500AID238958
Carbonic anhydrase 13Mus musculus (house mouse)Ki36,000.00000.00021.39749.9000AID238853
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)Ki8,000.00800.00001.34129.9700AID238515; AID238688
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
response to bacteriumCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID238317Inhibitory constant against carbonic anhydrase I2004Bioorganic & medicinal chemistry letters, Sep-06, Volume: 14, Issue:17
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.
AID238546Inhibition constant of anion against human carbonic anhydrase isozyme hCA IX2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
AID238515Inhibition constant of anion against human carbonic anhydrase isozyme hCA V2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
AID238410Inhibitory activity against human Carbonic anhydrase I2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238440Inhibitory activity against human Carbonic anhydrase II2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238544Inhibition constant of anion against human carbonic anhydrase isozyme hCA IV2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
AID265737Inhibition of human recombinant CA72006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions.
AID238327Inhibitory constant against carbonic anhydrase II2004Bioorganic & medicinal chemistry letters, Sep-06, Volume: 14, Issue:17
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.
AID552127Inhibition of human recombinant CA1 by stopped-flow CO2 hydration assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID238688Inhibitory activity against human carbonic anhydrase V expressed in Escherichia coli2004Bioorganic & medicinal chemistry letters, Nov-01, Volume: 14, Issue:21
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.
AID238958Inhibitory constant against methanoarchaeon Methanobacterium thermoautotrophicum (Cab)2004Bioorganic & medicinal chemistry letters, Sep-06, Volume: 14, Issue:17
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.
AID552128Inhibition of human recombinant CA2 by stopped-flow CO2 hydration assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID238853Inhibitory activity against mouse carbonic anhydrase XIII expressed in Escherichia coli TOP 102004Bioorganic & medicinal chemistry letters, Nov-01, Volume: 14, Issue:21
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.
AID238513Inhibition constant of anion against human carbonic anhydrase isozyme hCA I2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
AID238653Inhibitory constant against carbonic anhydrase IV; nt= not tested2004Bioorganic & medicinal chemistry letters, Sep-06, Volume: 14, Issue:17
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.
AID552129Inhibition of human recombinant CA6 by stopped-flow CO2 hydration assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID238441Inhibitory activity against human Carbonic anhydrase IV2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238442Inhibitory activity against human Carbonic anhydrase IX2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID238411Inhibitory activity against human Carbonic anhydrase V2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
AID552130Inhibition of Stylophora pistillata carbonic anhydrase by stopped-flow CO2 hydration assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID238687Inhibitory activity against human carbonic anhydrase I expressed in Escherichia coli2004Bioorganic & medicinal chemistry letters, Nov-01, Volume: 14, Issue:21
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.
AID552131Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID238607Inhibitory constant against Zn-Cam (Methanosarcina thermophila)2004Bioorganic & medicinal chemistry letters, Sep-06, Volume: 14, Issue:17
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.
AID238542Inhibition constant of anion against human carbonic anhydrase isozyme hCA II2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
AID238715Inhibitory activity against human carbonic anhydrase II expressed in Escherichia coli2004Bioorganic & medicinal chemistry letters, Nov-01, Volume: 14, Issue:21
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,322)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990144 (10.89)18.7374
1990's184 (13.92)18.2507
2000's450 (34.04)29.6817
2010's468 (35.40)24.3611
2020's76 (5.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 121.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index121.15 (24.57)
Research Supply Index7.26 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index229.37 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (121.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials14 (0.99%)5.53%
Reviews41 (2.91%)6.00%
Case Studies36 (2.55%)4.05%
Observational0 (0.00%)0.25%
Other1,320 (93.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]